4 - PACS Group, Inc. (0002001184) (Issuer)

3 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

4 - PACS Group, Inc. (0002001184) (Issuer)

Conference Call and Webcast Scheduled for Tomorrow, May 12, 2026, at 11:30 am ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2026. First Quarter 2026 Financial Highlights Revenue was $1.42 billion, an increase of 11.2% over prior year. Net income was $80.7 million, an increase of $52.3 million, or 184.2% from $28.4 million in the prior-year period. Adjusted EBITDA was $170.4 million, an increase of $72.8 million, or 74.6% from $97.6 million in the prior-year period.1 This result includes approximately

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its first quarter 2026 financial results on Monday, May 11, 2026. Management will host a call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=d7NGTHuZ or by dialing 877-407-0621 / 1-2

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of the post-acute care facility Ridgeway Senior Living in Anchorage, Alaska. It's the fourth PACS building in the state of Alaska. As part of the transaction, PACS has acquired land adjacent to the building, with plans to build a subsequent 150-bed skilled nursing facility, with an estimated completion date of 2028. "We're excited to expand our locally led, centrally supported model in Alaska," said Jason Murray, Chairman and Chief Executive Officer of PACS. "With our plans to build another skilled nursing center on the property, the

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock — PACS co-founder, first CFO, and one of the principal architects behind the company's success — on June 30, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427554117/en/Mark Hancock, PACS Group co-founder and retiring Chief Financial Officer Mr. Hancock co-founded PACS in 2013 alongside Jason Murray, PACS's Chairman and CEO, with just two post-acute care facilities in San Diego, CA. Under his leadership as CFO, PACS expanded from those two facilities to 323

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced today that it will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Tuesday, March 17, 2026. Jason Murray, Chief Executive Officer and Chairman of the Board, and Mark Hancock, Interim Chief Financial Officer and Executive Vice Chairman of the Board, will present on the company's operations, growth strategy and related information at 12:40-1:10 p.m. Eastern Time on March 17, 2026. The live webcast will be available at: https://summitcast.meetmax.com/view/2MZVg3DCx8a3zxe3mMMekq/E

Former CMS Deputy Administrator, Chief Medical Officer, and Current CEO of Optum Brings Unparalleled Clinical, Regulatory, and Healthcare Leadership to PACS Board PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Patrick H. Conway, MD, MSc, to its Board of Directors. Dr. Conway's addition to the PACS Board represents a landmark appointment for the post-acute and skilled nursing industry — bringing to the boardroom a rare combination of hands-on clinical experience, transformative federal regulatory leadership, large-scale health system executive experience, and deep expertise in quality, value-

Conference Call and Webcast Scheduled for Today, February 26, 2026, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the fiscal year and fourth quarter of 2025. Full Year 2025 Financial Highlights Revenue was $5.29 billion, an increase of 29.3% over prior year. Net income was $191.5 million. Adjusted EBITDA was $505.0 million. Adjusted EBITDAR was $883.9 million. Fourth Quarter 2025 Financial Highlights Revenue was $1.36 billion, an increase of 12.4% over the same period prior year. Net income was $59.

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its fiscal year and fourth quarter 2025 financial results after market close on Thursday, February 26, 2026. Management will host a call on Thursday, February 26, 2026, at 5:30 p.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=kswnl

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00

Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

Citigroup resumed coverage of PACS Group with a rating of Buy and set a new price target of $45.00

Macquarie initiated coverage of PACS Group with a rating of Outperform and set a new price target of $35.00

144 - PACS Group, Inc. (0002001184) (Subject)

8-K - PACS Group, Inc. (0002001184) (Filer)

10-Q - PACS Group, Inc. (0002001184) (Filer)

DEFA14A - PACS Group, Inc. (0002001184) (Filer)

DEF 14A - PACS Group, Inc. (0002001184) (Filer)

8-K - PACS Group, Inc. (0002001184) (Filer)

8-K - PACS Group, Inc. (0002001184) (Filer)

8-K - PACS Group, Inc. (0002001184) (Filer)

8-K - PACS Group, Inc. (0002001184) (Filer)

8-K - PACS Group, Inc. (0002001184) (Filer)

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership

Former CMS Deputy Administrator, Chief Medical Officer, and Current CEO of Optum Brings Unparalleled Clinical, Regulatory, and Healthcare Leadership to PACS Board PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Patrick H. Conway, MD, MSc, to its Board of Directors. Dr. Conway's addition to the PACS Board represents a landmark appointment for the post-acute and skilled nursing industry — bringing to the boardroom a rare combination of hands-on clinical experience, transformative federal regulatory leadership, large-scale health system executive experience, and deep expertise in quality, value-

SC 13G - PACS Group, Inc. (0002001184) (Subject)

SC 13G - PACS Group, Inc. (0002001184) (Subject)

SC 13G - PACS Group, Inc. (0002001184) (Subject)

Conference Call and Webcast Scheduled for Tomorrow, May 12, 2026, at 11:30 am ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2026. First Quarter 2026 Financial Highlights Revenue was $1.42 billion, an increase of 11.2% over prior year. Net income was $80.7 million, an increase of $52.3 million, or 184.2% from $28.4 million in the prior-year period. Adjusted EBITDA was $170.4 million, an increase of $72.8 million, or 74.6% from $97.6 million in the prior-year period.1 This result includes approximately

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its first quarter 2026 financial results on Monday, May 11, 2026. Management will host a call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=d7NGTHuZ or by dialing 877-407-0621 / 1-2

Conference Call and Webcast Scheduled for Today, February 26, 2026, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the fiscal year and fourth quarter of 2025. Full Year 2025 Financial Highlights Revenue was $5.29 billion, an increase of 29.3% over prior year. Net income was $191.5 million. Adjusted EBITDA was $505.0 million. Adjusted EBITDAR was $883.9 million. Fourth Quarter 2025 Financial Highlights Revenue was $1.36 billion, an increase of 12.4% over the same period prior year. Net income was $59.

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its fiscal year and fourth quarter 2025 financial results after market close on Thursday, February 26, 2026. Management will host a call on Thursday, February 26, 2026, at 5:30 p.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=kswnl

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=ngVWINHF or by dialing 877-407-0621 / +1 215-268-9899. A recording of the call will be available for replay via the website for